Pfizer is getting into the obesity treatment industry with a multi-billion-dollar deal for Mestera. Currently, Pfizer and Mestera don’t have an obesity drug on the market. The deal between the two ...

A new partnership between the U.S. government and Pfizer is set to reshape how some Americans purchase prescription drugs. Under the agreement announced Tuesday, Pfizer will begin offering its ...

Pfizer shares surged 14% over two trading days this past week after joining with Trump’s administration to announce an agreement they positioned as both bolstering U.S. leadership in biopharma ...

(Reuters) -Pfizer on Thursday closed its up to $10 billion acquisition of Metsera after winning shareholder approval, gaining a foothold in the fast-growing obesity market following a fierce bidding ...